|
|
.
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
ICD-10 (CM) Code and Descriptor
|
R92.0 |
Mammographic microcalcification found on diagnostic imaging of breast
|
R920 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 38.23%
|
34.60%
|
14.42%
|
6.40%
|
2.88%
|
1.45%
|
0.67%
|
0.39%
|
0.21%
|
0.12%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R92.0*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
77065
|
DX MAMMO INCL CAD UNI |
9,584
|
9,585
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
6,100
|
6,100
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
4,931
|
5,989
|
|
19081
|
BX BREAST 1ST LESION STRTCTC |
3,631
|
3,633
|
|
77066
|
DX MAMMO INCL CAD BI |
3,089
|
3,089
|
|
A4648
|
IMPLANTABLE TISSUE MARKER |
2,221
|
2,451
|
|
76642
|
ULTRASOUND BREAST LIMITED |
1,308
|
1,319
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
979
|
1,107
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
939
|
941
|
|
76641
|
ULTRASOUND BREAST COMPLETE |
710
|
719
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
698
|
1,318
|
|
88360
|
TUMOR IMMUNOHISTOCHEM/MANUAL |
681
|
1,378
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
365
|
1,731
|
|
J2001
|
LIDOCAINE INJECTION |
339
|
4,724
|
|
76098
|
X-RAY EXAM SURGICAL SPECIMEN |
282
|
293
|
|
19083
|
BX BREAST 1ST LESION US IMAG |
262
|
262
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
253
|
253
|
|
19082
|
BX BREAST ADD LESION STRTCTC |
218
|
221
|
|
19281
|
PERQ DEVICE BREAST 1ST IMAG |
163
|
163
|
|
88361
|
TUMOR IMMUNOHISTOCHEM/COMPUT |
158
|
279
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R92.0 related to the following DRG Codes:
600-601
|
